Dow Jones

39 872,99

0,17%

DAX

Inscrivez-vous pour des alertes en temps réel, un portefeuille personnalisé et des mouvements de marché.

S'inscrire

ARAV

Aravive (ARAV)

Aravive Inc

De:

Actualités Réglementées

Mots clefs:

Trier par:

Actualités Non-réglementées

Showing the most relevant articles for your search:NASDAQ:ARAV

1 2 3 4 5 Suivant >>

Date	Heure	Source	Titre	Symbole	Société
08/02/2024	13h00	Edgar (US Regulatory)	Form 15-12G - Securities registration termination [Section 12(g)]	NASDAQ:ARAV	Aravive Inc
02/02/2024	06h15	Edgar (US Regulatory)	Form EFFECT - Notice of Effectiveness	NASDAQ:ARAV	Aravive Inc
29/01/2024	22h17	Edgar (US Regulatory)	Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments	NASDAQ:ARAV	Aravive Inc
29/01/2024	22h10	Edgar (US Regulatory)	Form POS AM - Post-Effective amendments for registration statement	NASDAQ:ARAV	Aravive Inc
29/01/2024	22h06	Edgar (US Regulatory)	Form 25 - Notification of the removal from listing and registration of matured, redeemed or retired securities	NASDAQ:ARAV	Aravive Inc
17/01/2024	22h22	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:ARAV	Aravive Inc
17/01/2024	22h09	GlobeNewswire Inc.	Aravive, Inc. to Delist from The Nasdaq Stock Market	NASDAQ:ARAV	Aravive Inc
09/11/2023	22h05	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:ARAV	Aravive Inc
22/09/2023	23h04	Edgar (US Regulatory)	Form DEFR14A - Revised definitive proxy soliciting materials	NASDAQ:ARAV	Aravive Inc
05/09/2023	22h05	Edgar (US Regulatory)	Form DEF 14A - Other definitive proxy statements	NASDAQ:ARAV	Aravive Inc
25/08/2023	13h30	Edgar (US Regulatory)	Form ARS - Annual Report to Security Holders	NASDAQ:ARAV	Aravive Inc
24/08/2023	23h18	Edgar (US Regulatory)	Form PRE 14A - Other preliminary proxy statements	NASDAQ:ARAV	Aravive Inc
14/08/2023	22h06	Edgar (US Regulatory)	Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB	NASDAQ:ARAV	Aravive Inc
20/06/2023	22h12	Edgar (US Regulatory)	Securities Registration Statement (simplified Form) (s-3)	NASDAQ:ARAV	Aravive Inc
05/06/2023	22h07	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:ARAV	Aravive Inc
10/05/2023	22h08	Edgar (US Regulatory)	Quarterly Report (10-q)	NASDAQ:ARAV	Aravive Inc
01/05/2023	18h50	Edgar (US Regulatory)	Confidential Treatment Order (ct Order)	NASDAQ:ARAV	Aravive Inc
19/04/2023	22h32	Edgar (US Regulatory)	Securities Registration: Employee Benefit Plan (s-8)	NASDAQ:ARAV	Aravive Inc
11/04/2023	22h08	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:ARAV	Aravive Inc
11/04/2023	22h07	Edgar (US Regulatory)	Initial Statement of Beneficial Ownership (3)	NASDAQ:ARAV	Aravive Inc
15/03/2023	12h07	Edgar (US Regulatory)	Annual Report (10-k)	NASDAQ:ARAV	Aravive Inc
14/02/2023	22h02	Edgar (US Regulatory)	Statement of Ownership (sc 13g)	NASDAQ:ARAV	Aravive Inc
28/12/2022	22h01	Edgar (US Regulatory)	Amended Statement of Beneficial Ownership (sc 13d/a)	NASDAQ:ARAV	Aravive Inc
29/11/2022	14h04	Dow Jones News	Aravive Shares Rise Premarket on FDA Fast-Track Designation for Batiraxcept	NASDAQ:ARAV	Aravive Inc
17/11/2022	22h06	Edgar (US Regulatory)	Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a)	NASDAQ:ARAV	Aravive Inc
10/11/2022	16h15	TipRanks	H.C. Wainwright Sticks to Their Buy Rating for Aravive (ARAV)	NASDAQ:ARAV	Aravive Inc
28/10/2022	22h12	Edgar (US Regulatory)	Small Company Offering and Sale of Securities Without Registration (d)	NASDAQ:ARAV	Aravive Inc
10/10/2022	22h05	GlobeNewswire Inc.	Aravive Receives Third Development Milestone from 3D Medicines	NASDAQ:ARAV	Aravive Inc
26/09/2022	14h00	GlobeNewswire Inc.	Aravive to Participate in the Cantor Fitzgerald Oncology & HemOnc Conference	NASDAQ:ARAV	Aravive Inc
06/09/2022	22h05	GlobeNewswire Inc.	Aravive to Participate in H.C. Wainwright 24th Annual Global Investment Conference	NASDAQ:ARAV	Aravive Inc